Technology

First implant to treat depression unveiled: new brain chip set to rival Elon Musk’s Nueralink

Inner Cosmos has introduced the first brain implant to treat depression.  The digital pill is the smallest and least invasive technology to date - the implant is about the size of a dime
Written by admin

During Elon Musk‘s Neuralink expects to begin human trials in six months, a neurotech company unveiled a device that treats depression and is now in the skull of the first patient.

Inner Cosmos’ “digital pill” consists of two parts: an electrode that sits under the skin of the scalp, and the “prescription pod” that slips onto the user’s hair to power the device.

The implant sends tiny electrical impulses to the brain region affected by depression – the left dorsolateral prefrontal cortex – once a day for 15 minutes.

And the external device does not need to be worn on the head when no treatment is being performed.

The St. Louise, Missouri-based trial patient is scheduled to test the Inner Cosmos innovation for a year, and the company plans to start another human trial next month.

Inner Cosmos has introduced the first brain implant to treat depression.  The digital pill is the smallest and least invasive technology to date - the implant is about the size of a dime

Inner Cosmos has introduced the first brain implant to treat depression. The digital pill is the smallest and least invasive technology to date – the implant is about the size of a dime

Implants to treat all brain orientations are making waves in the industry as several companies battle to bring their firsts to market.

Musk’s Neuralink recently conducted a product demonstration showing off its chip in a monkey’s brain, which allowed it to control a keyboard on a screen to input full sentences.

Synchron began human trials in July of his brain implant, which allows the wearer to control a computer with their thoughts alone.

The company’s Stentrode brain implant, about the size of a paperclip, will be implanted in six patients with severe paralysis in New York and Pittsburgh.

Stentrode will enable patients to control digital devices simply by thinking and enable them to complete daily tasks including texting, email and online shopping.

Research institutions are also developing brain chips.

Bristol’s Southmead Hospital is believed to be the first in the world to implant a device to reverse the symptoms of Parkinson’s.

However, Inner Cosmos’ digital pill is the smallest and least invasive technology yet – the implant is about the size of a dime.

And the company compares the external pod to charging an Apple Watch.

The surgery for the implant takes 30 minutes in an outpatient facility.

Inner Cosmos was founded by entrepreneur Meron Gribetz, who was diagnosed with Attention Deficit Disorder as a child.

“Our mission is to create a world that will restore humanity’s cognitive power by rebalancing the human spirit,” Gribetz said.

“The world is in a state of severe disorder, resulting in disordered perception

“The effects are being felt by millions of people and leading to increasing levels of depression.

“We believe our approach can improve the lives of people suffering from depression and can eventually be extended to other cognitive disorders.”

The goal of Inner Cosmos is to move away from prescription drugs and towards “more effective treatment”.

‘Depression, attention and anxiety that we treat. Just to underscore this point, there are 140 million Americans using attention or depression medication each year, that’s more users than iPhones,” Gribetz said in a 2022 presentation.

Inner Cosmos'

Inner Cosmos’ “digital pill” consists of two parts: an electrode that sits under the skin of the scalp, and the “prescription pod” that slips onto the user’s hair to power the device

The implant sends pulses once a day for 15 minutes to the brain region affected by depression – the left dorsolateral prefrontal cortex.  And the external device does not need to be worn on the head when no treatment is being performed

The implant sends pulses once a day for 15 minutes to the brain region affected by depression – the left dorsolateral prefrontal cortex. And the external device does not need to be worn on the head when no treatment is being performed

The Inner Cosmos digital pill is powered by a smartphone app that also displays mood and depression graphs that can be shared with a doctor.

Gribetz said this is the first time doctors have had access to this type of data, “saving the healthcare industry billions for misdiagnosing major suicidal depression,” he said.

‘[The implant] is 10 times smaller than anything else you’ve heard of worldwide, on the BCI brain chips [brain computer interface] market, and we’re really excited,” Gribetz said. “It took us six years to build this thing.”

If you liked this article…

brain implant helps reverse the symptoms of Parkinson’s in the first patient to receive treatment as part of a medical study

‘Read minds’ Brain Implant Allows Californian Man36, “talking” again after being paralyzed from the neck down at 20

Elon Musk’s Neuralink rival Synchronously begins human experiments his BRAIN IMPLANT, which allows the wearer to control a computer with just their thoughts

About the author

admin

Leave a Comment